ACOR
Acorda Therapeutics, Inc.
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
181 hedge funds and large institutions have $1.42B invested in Acorda Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 65 increasing their positions, 57 reducing their positions, and 15 closing their positions.
Holders
181
Holders Change
+15
Holders Change %
+9.04%
% of All Funds
4.15%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
30
Increased
65
Reduced
57
Closed
15
Calls
$18.7M
Puts
$28.5M
Net Calls
-$9.75M
Net Calls Change
+$12.6M
Top Buyers
| 1 |
1
Invesco
Atlanta,
Georgia
|
$37.6M |
| 2 |
2
Renaissance Technologies
New York
|
$19.5M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$139M |
| 4 |
4
BlackRock
New York
|
$197M |
| 5 |
5
D.E. Shaw & Co
New York
|
$16.2M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
201
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
202
Wolverine Trading
Chicago,
Illinois
| – | – | – | – |
|
203
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|
|
DAM
204
DLD Asset Management
New York
| – | – | – | – |
|
|
SAM
205
Symphony Asset Management
San Francisco,
California
| – | – | – | – |
|
|
VFA
206
Valeo Financial Advisors
Carmel,
Indiana
| $0 | 17 | – | – |
|
207
Citadel Advisors
Miami,
Florida
| – | – | – | – |
|